Lab testing giant Quest Diagnostics confirms patients’ personal and health data was compromised during breach
Reported by TechCrunch · techcrunch.com ·
Quest is the latest in a series of healthcare technology companies that have been hacked in recent months.
Story context
What to watch: Monitor Healthcare & Pharma for follow-through — insufficient signal for directional thesis.
Latest session change: $DGX -0.58%
How this was labelled
TechCrunch published it, and Wook filed it under Healthcare & Pharma. No strongly worded term either way, so it reads neutral at low severity — a factual headline rather than a charged one. It was matched to $DGX. The preview above is the publisher's own wording.
When it landed
It landed while New York was open, so the session move beside it may include the reaction.
Where the price is
$DGX last traded at $241.87, -0.58% on the session. That is 2.8% below its 52-week high of $248.84 and 41% above its low of $171.18 — within a tenth of its 52-week high. The year's range spans 45% from low to high: a moderate band. These are latest-session quotes, not live prices.
How much is being written
Wook has stored 4 stories about $DGX in the last 30 days, 4 of them this week. At the 30-day pace you would expect about 1 a week, so this week is running well ahead of normal — something has drawn extra attention. Across those stories the wording ran 50% bullish, 50% neutral and 0% bearish; this one reads neutral, so it sits with the majority of the run. This is the only one from TechCrunch; the rest came from other outlets. 12 of them are listed beside this one.
The backdrop
Healthcare stories tend to turn on approvals, trial data and pricing: an FDA decision or a trial readout can move a single drugmaker sharply, while drug-pricing policy moves the whole group. On Wook's supply-chain scanner, Health Care reads calm today — no unusual stress in the filings and disclosures it reads.
Where to look next
The $DGX page has the full chart, the filings and the valuation model behind these figures. Comparing how two or three outlets frame the same story is the quickest way to separate the facts from the angle. Wook AI, above, can pull live figures and do the math — how far $DGX is from its high, or how this week's coverage compares — on request.
What this page is not saying
The tone and severity labels come from a fixed word list — no editor, no AI — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
TechCrunch published this on October 23, 2026. $DGX has moved -0.13% ($242.18 to $241.87). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.